You are viewing the site in preview mode

Skip to main content

Table 2 Comparison of anthropometric, clinical, and fasting metabolic parameters in participants of each sex in the NAFLD and control groups

From: A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test

  Con NAFLD
Male(n = 139) Female(n = 178) Male(n = 85) Female(n = 70)
Age (Year) 45 ± 14 42 ± 13 44 ± 12 51 ± 10
BMI (kg/m2) 25.57 ± 3.17 23.58 ± 3.04 29.29 ± 3.55## 28.58 ± 4.14##
FBG (mmol/L) 5.40 (5.07,5.79) 5.22 (4.93,5.54) 5.79 (5.40,6.47) ## 5.78 (5.37,6.49) ##
FINS (mmol/L) 9.40 (6.48,12.34) 8.63 (6.14,11.60) 16.40 (11.17,20.57) ## 15.33 (11.45,19.34) ##
HOMA-IR 2.09 (1.56,3.07) 2.07 (1.39,2.76) 4.28 (3.04,5.86) ## 4.07 (2.97,5.67) ##
TC (mmol/L) 4.43 ± 0.86 4.71 ± 1.02 4.82 ± 0.99# 5.21 ± 1.10#
TG (mmol/L) 0.99 ± 0.30 0.86 ± 0.26 1.57 ± 0.48## 1.78 ± 0.77##
HDL-C (mmol/L) 1.18 ± 0.26 1.39 ± 0.29 1.06 ± 0.16## 1.24 ± 0.24##
LDL-C (mmol/L) 2.79 ± 0.60 2.90 ± 0.76 3.14 ± 0.71## 3.34 ± 0.78##
  1. Data are mean ± standard deviation or median (interquartile range)
  2. Abbreviations: Con control group, BMI body mass index, FBG fasting blood glucose, FINS fasting plasma insulin concentration, HOMA-IR homeostasis model assessment of insulin resistance, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein-cholesterol, LDL-C low-density lipoprotein-cholesterol
  3. # P < 0.05, compared with the Con group. ## P < 0.01, compared with the Con group